HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delan Khalid Selected Research

Neuroblastoma

1/2023Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors.
1/2022Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Delan Khalid Research Topics

Disease

2Neuroblastoma
01/2023 - 01/2022
1Transient Myeloproliferative Syndrome
01/2024
1Leukemia
11/2023
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2023
1Neoplasms (Cancer)
01/2023
1Disease Progression
01/2023
1Carcinogenesis
01/2023

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
11/2023 - 01/2023
1Protein Isoforms (Isoforms)IBA
01/2024
1avapritinibIBA
11/2023
1Proteins (Proteins, Gene)FDA Link
11/2023
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1AntibodiesIBA
01/2022
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2022

Therapy/Procedure

3Therapeutics
11/2023 - 01/2022
1Immunotherapy
01/2022